Contact this trialFirst, we need to learn more about you.
Alkylating agent
Sirolimus + Chemotherapy for High-Risk Pediatric Cancers
Recruiting3 awardsPhase 2
Houston, Texas
This trial is testing whether a maintenance regimen of continuous sirolimus and metronomic chemotherapy can improve the 2-year progression-free survival in children with high-risk solid tumors, as compared to observation alone following completion of "standard" therapy.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.